FiftyBidsGovernment contracts and grants, in one plain-English search.

Back to search

Sources sought

Development/Production - Kidney GEC-Specific AAV Vector

The following is a Sources Sought/Request for Information notice. This posted notice is not a Pre- Solicitation or Solicitation document.

Notice typeSources Sought: Market research. The agency wants to know who can do this work. Answering is free and can get the job set aside for small businesses.
Who's buyingRpo East (36c24e), Veterans Affairs, Department of
WhereWork location not listed. The buying office is in Pittsburgh, Pennsylvania.
DeadlineWed, Nov 4, 2026 at 12:00 PM EST (12 days left)
Who can bidOpen to any business (no set-aside listed)
IndustryNAICS 541714 (Research and Development in Biotechnology (except Nanobiotechnology))
Solicitation #36C24E27Q0009
PostedWed, Oct 21, 2026
ContactMae McGarry, [email protected]

Heads-up: Brand-name or equal product

Open the official posting

From the notice

The following is a Sources Sought/Request for Information notice. This posted notice is not a Pre- Solicitation or Solicitation document. The government is not currently soliciting bids, quotes or proposals at this time; however, reserves the right to do so at a later date. The Harry S Truman Memorial Veterans Hospital, Columbia, MO 65201 has a brand name only requirement for Development/Production- Kidney GEC- Specific AAV Vector. Statement of Work (SOW) For GEC Targeted Adeno Associated Virus Vector Development Contract Description: Development and production of a kidney glomerular endothelial cell specific AAV vector for VA preclinical research. 1.0 Scope of Work: 1.1 This requirement is a VA ORD Merit funded project (#1I21RD001234-01) to develop a kidney glomerular endothelial cell specific viral vector. 1.2 The goal of the project is to build a homing peptide enabled vector platform capable of targeting the glomerular endothelium to treat kidney injury and disease and to enhance traditional pharmacologic approaches. 1.3 The work will modify the capsid of an endothelial specific, non immunogenic viral vector by incorporating a peptide that specifically targets kidney glomerular endothelial cells (GEC), with the objective of increasing specificity, reducing off target transduction, and overcoming known limitations in vector targeting to the kidney. 2.0 Background: 2.1 This requirement in response to RD-01-PILT: ISRM Pilot Project Award I21 was selected for funding by ORD;

We may have shortened this. The official posting is the record. We are not affiliated with the agency that published it.